Novasys pays $650,000 to use Curon patents

By Elaine Rigoli

Tampa, Fla., May 12 - Curon Medical, Inc. and Novasys Medical, Inc. have entered into an agreement for a worldwide, exclusive license of Curon patents for which Novasys is paying $650,000 in cash.

With this agreement, Novasys can use certain intellectual property of Curon for the treatment of urinary incontinence and other genito-urinary conditions in men and women, according to a news release.

As the intellectual property involved is unrelated to Curon's core business, this transaction does not affect Curon's applications of radiofrequency energy for the treatment of gastroesophageal reflux disease or bowel incontinence, the release said.

Curon Medical, based in Fremont, Calif., develops products for the treatment of gastrointestinal disorders.

Novasys Medical is a Newark, Calif.-based company that develops therapies for women's health.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.